Bikaji Foods International Ltd IPO

Incorporated in 1983, Kolkata-based Tarsons Products manufactures laboratory products that are used in various research organisations, pharmaceutical companies, academia institutes, hospitals and diagnostic centres.

The company plans to go public and here’s all you need to know about this IPO.

Here’s the consolidated financial information for the last three years:

• Well-established brand with pan-India recognition;
• Diversified product portfolio focused on various consumer segments and markets;
• Strategically located, large scale sophisticated manufacturing facilities with stringent quality standards;
• Extensive pan-India and global distribution network, arrangements with reputed retail chains and growing e-commerce and exports channel;
• Extensive distribution network in India;

• The reputation and consumer goodwill associated with its brand are critical for the success of its business. An inability to maintain or enhance the popularity of its "Bikaji" brand may adversely impact its business prospects and financial performance.
• The company is significantly dependent on the sale of its Bhujia Products. An inability to anticipate and adapt to evolving consumer tastes, preferences and demand for particular products, or ensure product quality or reduction in the demand of its Bhujia Products may adversely impact demand for its products, brand loyalty and consequently its business prospects and financial performance.
• The current and continuing impact of the COVID-19 pandemic on its business and operations, including its impact on the ability or desire of consumers to purchase its products, may have an adverse effect on its business prospects and future financial performance.
• Any slowdown or interruption to its manufacturing operations or under-utilization of its existing or future manufacturing facilities may have an adverse impact on its business and financial performance.
• Its proposed capacity expansion plans relating to its manufacturing facility and proposed contract manufacturing facilities are subject to the risk of unanticipated delays in implementation and cost overruns.

• Implement distinctive growth strategies for its core markets, focus markets and other markets
• Establish strategically located new manufacturing facilities to pursue growth in its focus and other markets
• Continue to use advanced technology to further optimise its operations
• Further strengthen its brand
• Implement distinctive growth strategies for its core markets, focus markets and other markets